Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance

Suresh T Chari, Mauricio Zapiach, Dhiraj Yadav, Robert A. Rizza

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background/Aims: To gain insights into pathogenesis of pancreatic cancer-associated diabetes. Methods: Using homeostasis model assessment (HOMA), we estimated β-cell function (BCF) and insulin resistance (IR) from fasting plasma glucose (FPG) and insulin in 67 normoglycemic controls and 62 age- and BMI-matched normoglycemic pancreatic cancer patients. In addition, we studied 73 pancreatic cancer subjects with glucose intolerance; 21 had impaired FPG and 51 had diabetes. Results: BCF was similar in controls and normoglycemic pancreatic cancer subjects (64 ± 5 vs. 78 ± 9, p = ns), while IR was higher in pancreatic cancer subjects with normal FPG (1.6 ± 0.6 vs. 1.1 ± 0.1, p = 0.002). Among pancreatic cancer subjects, those with impaired FPG had markedly decreased BCF compared to those with normal FPG (44 ± 5 vs. 78 ± 9, p < 0.02) without significant difference in IR (1.9 ± 0.2 vs. 1.6 ± 0.6, p = ns). In cancer subjects, those with diabetes had markedly increased IR compared to those with impaired FPG (3.2 ± 0.3 vs. 1.9 ± 0.2, p < 0.0001), while the BCF was similar (37 ± 4 vs. 44 ± 5). Conclusion: Diabetes associated with pancreatic cancer is likely due to a combination of marked decline in BCF and increased insulin resistance.

Original languageEnglish (US)
Pages (from-to)229-233
Number of pages5
JournalPancreatology
Volume5
Issue number2-3
DOIs
StatePublished - 2005

Fingerprint

Glucose Intolerance
Pancreatic Neoplasms
Insulin Resistance
Homeostasis
Fasting
Glucose
Insulin
Neoplasms

Keywords

  • β-Cell function
  • Diabetes
  • Homeostasis model assessment
  • Insulin resistance
  • Pancreatic cancer

ASJC Scopus subject areas

  • Endocrinology
  • Gastroenterology

Cite this

Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance. / Chari, Suresh T; Zapiach, Mauricio; Yadav, Dhiraj; Rizza, Robert A.

In: Pancreatology, Vol. 5, No. 2-3, 2005, p. 229-233.

Research output: Contribution to journalArticle

@article{cfbcb066d7ff4ab4ae59bac9998b9f2d,
title = "Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance",
abstract = "Background/Aims: To gain insights into pathogenesis of pancreatic cancer-associated diabetes. Methods: Using homeostasis model assessment (HOMA), we estimated β-cell function (BCF) and insulin resistance (IR) from fasting plasma glucose (FPG) and insulin in 67 normoglycemic controls and 62 age- and BMI-matched normoglycemic pancreatic cancer patients. In addition, we studied 73 pancreatic cancer subjects with glucose intolerance; 21 had impaired FPG and 51 had diabetes. Results: BCF was similar in controls and normoglycemic pancreatic cancer subjects (64 ± 5 vs. 78 ± 9, p = ns), while IR was higher in pancreatic cancer subjects with normal FPG (1.6 ± 0.6 vs. 1.1 ± 0.1, p = 0.002). Among pancreatic cancer subjects, those with impaired FPG had markedly decreased BCF compared to those with normal FPG (44 ± 5 vs. 78 ± 9, p < 0.02) without significant difference in IR (1.9 ± 0.2 vs. 1.6 ± 0.6, p = ns). In cancer subjects, those with diabetes had markedly increased IR compared to those with impaired FPG (3.2 ± 0.3 vs. 1.9 ± 0.2, p < 0.0001), while the BCF was similar (37 ± 4 vs. 44 ± 5). Conclusion: Diabetes associated with pancreatic cancer is likely due to a combination of marked decline in BCF and increased insulin resistance.",
keywords = "β-Cell function, Diabetes, Homeostasis model assessment, Insulin resistance, Pancreatic cancer",
author = "Chari, {Suresh T} and Mauricio Zapiach and Dhiraj Yadav and Rizza, {Robert A.}",
year = "2005",
doi = "10.1159/000085276",
language = "English (US)",
volume = "5",
pages = "229--233",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",
number = "2-3",

}

TY - JOUR

T1 - Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance

AU - Chari, Suresh T

AU - Zapiach, Mauricio

AU - Yadav, Dhiraj

AU - Rizza, Robert A.

PY - 2005

Y1 - 2005

N2 - Background/Aims: To gain insights into pathogenesis of pancreatic cancer-associated diabetes. Methods: Using homeostasis model assessment (HOMA), we estimated β-cell function (BCF) and insulin resistance (IR) from fasting plasma glucose (FPG) and insulin in 67 normoglycemic controls and 62 age- and BMI-matched normoglycemic pancreatic cancer patients. In addition, we studied 73 pancreatic cancer subjects with glucose intolerance; 21 had impaired FPG and 51 had diabetes. Results: BCF was similar in controls and normoglycemic pancreatic cancer subjects (64 ± 5 vs. 78 ± 9, p = ns), while IR was higher in pancreatic cancer subjects with normal FPG (1.6 ± 0.6 vs. 1.1 ± 0.1, p = 0.002). Among pancreatic cancer subjects, those with impaired FPG had markedly decreased BCF compared to those with normal FPG (44 ± 5 vs. 78 ± 9, p < 0.02) without significant difference in IR (1.9 ± 0.2 vs. 1.6 ± 0.6, p = ns). In cancer subjects, those with diabetes had markedly increased IR compared to those with impaired FPG (3.2 ± 0.3 vs. 1.9 ± 0.2, p < 0.0001), while the BCF was similar (37 ± 4 vs. 44 ± 5). Conclusion: Diabetes associated with pancreatic cancer is likely due to a combination of marked decline in BCF and increased insulin resistance.

AB - Background/Aims: To gain insights into pathogenesis of pancreatic cancer-associated diabetes. Methods: Using homeostasis model assessment (HOMA), we estimated β-cell function (BCF) and insulin resistance (IR) from fasting plasma glucose (FPG) and insulin in 67 normoglycemic controls and 62 age- and BMI-matched normoglycemic pancreatic cancer patients. In addition, we studied 73 pancreatic cancer subjects with glucose intolerance; 21 had impaired FPG and 51 had diabetes. Results: BCF was similar in controls and normoglycemic pancreatic cancer subjects (64 ± 5 vs. 78 ± 9, p = ns), while IR was higher in pancreatic cancer subjects with normal FPG (1.6 ± 0.6 vs. 1.1 ± 0.1, p = 0.002). Among pancreatic cancer subjects, those with impaired FPG had markedly decreased BCF compared to those with normal FPG (44 ± 5 vs. 78 ± 9, p < 0.02) without significant difference in IR (1.9 ± 0.2 vs. 1.6 ± 0.6, p = ns). In cancer subjects, those with diabetes had markedly increased IR compared to those with impaired FPG (3.2 ± 0.3 vs. 1.9 ± 0.2, p < 0.0001), while the BCF was similar (37 ± 4 vs. 44 ± 5). Conclusion: Diabetes associated with pancreatic cancer is likely due to a combination of marked decline in BCF and increased insulin resistance.

KW - β-Cell function

KW - Diabetes

KW - Homeostasis model assessment

KW - Insulin resistance

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=19944404452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944404452&partnerID=8YFLogxK

U2 - 10.1159/000085276

DO - 10.1159/000085276

M3 - Article

VL - 5

SP - 229

EP - 233

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

IS - 2-3

ER -